drugset / Trial / NCT04712734
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, adaptive, repeat-dose study to evaluate the safety, tolerability, and pharmacokinetics of iloperidone long-acting injection (LAI) in patients with schizophrenia.
Timeline
- Start
- 2021-01-13
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloperidone | Small molecule | — | Oral |